BriaCell Therapeutics Corp. (BCTXW) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 West Vancouver, BC, 캐나다. 현재 CEO는 William V. Williams.
BCTXW 을(를) 보유 IPO 날짜 2012-08-13, 16 명의 정규직 직원, 에 상장 NASDAQ Capital Marke, 시가총액 $1.7K.
BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
